|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:acquisition
|
Acquired by Bausch Health in 2013
|
|
gptkbp:brand
|
gptkb:Vigamox
gptkb:Blink
gptkb:Systane
gptkb:Bepreve
gptkb:Lotemax
gptkb:Tobradex
gptkb:Zymar
gptkb:Zymaxid
gptkb:Ultraman
gptkb:Biofinity
gptkb:Pure_Vision
Optive
Ocuvite
Artelac
Soothe
Renu
Soothe Eye Drops
Soothe Gel Drops
Soothe Hydration
Soothe XP
Zylet
Refresh
Moxeza
Similasan
Lacri-Lube
Thera Tears
Alrex
Besivance
Soothe Nighttime Gel Drops
Soothe XP Gel Drops
|
|
gptkbp:ceo
|
gptkb:Joseph_C._Papa
|
|
gptkbp:employees
|
Over 13,000
|
|
gptkbp:founded
|
1853
|
|
gptkbp:founder
|
John Bausch
|
|
gptkbp:global_presence
|
gptkb:Yes
|
|
gptkbp:headquarters
|
gptkb:Rochester,_New_York
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Bausch + Lomb Eye Products Inc.
|
|
gptkbp:industry
|
Healthcare
|
|
gptkbp:invention
|
Numerous in ophthalmic products
|
|
gptkbp:market
|
Global
|
|
gptkbp:parent_company
|
gptkb:Bausch_Health_Companies_Inc.
|
|
gptkbp:partnerships
|
Various healthcare providers
|
|
gptkbp:products
|
gptkb:sunglasses
Eye drops
Surgical products
|
|
gptkbp:research_and_development
|
gptkb:Yes
|
|
gptkbp:revenue
|
$3.5 billion (2020)
|
|
gptkbp:subsidiaries
|
Bausch + Lomb Australia Pty Ltd.
Bausch + Lomb Canada Inc.
Bausch + Lomb India Pvt. Ltd.
Bausch + Lomb UK Ltd.
|
|
gptkbp:website
|
www.bausch.com
|
|
gptkbp:bfsParent
|
gptkb:Bausch_&_Lomb
|
|
gptkbp:bfsLayer
|
5
|